Literature DB >> 27358257

Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.

Freja Lærke Sand1, Christian Munk1, Signe Marie Jensen2, Malene Frøsig Svahn1, Kirsten Frederiksen2, Susanne K Kjær3.   

Abstract

BACKGROUND: High-risk human papillomavirus (HPV) is essential for developing high-grade cervical intraepithelial neoplasia (CIN2 and CIN3) and has also been associated with noncervical anogenital cancers. However, limited knowledge exists about the long-term risk for anal, vulvar, and vaginal cancer following CIN2 or CIN3 diagnosis.
METHODS: In a nationwide cohort study, we followed nearly 2.8 million women born in 1918-1990 who were recorded as living in Denmark between January 1, 1978 and December 31, 2012. The cohort was linked to multiple nationwide registers to obtain information on cancer diagnoses and confounders. Follow-up started when the women reached 18 years, date of immigration, or January 1978, and continued until emigration, death, December 31, 2012, or the date of first diagnosis of anogenital or rectal cancer.
RESULTS: Women with a history of CIN2 or CIN3 had higher risks for subsequent anal, vulvar, and vaginal cancer than women with no such history. The relative risks were higher for CIN3 than CIN2. No excess risk was found for rectal cancer. Analyses in which time since first CIN3 was taken into account showed increased relative risks for anal [HR = 4.8; 95% confidence interval (CI), 3.3-7.0], vulvar (HR = 3.2; 95% CI, 2.0-5.3), and vaginal (HR = 5.5; 95% CI, 2.4-12.3) cancers ≥25 years after CIN3 diagnosis.
CONCLUSION: Women with a history of CIN2 or CIN3 have a long-term increased relative risk for developing anal, vulvar, and vaginal cancer due to an impaired ability to control a persistent HPV infection. IMPACT: This finding adds to our understanding of the relation between HPV infection and noncervical anogenital cancer. Cancer Epidemiol Biomarkers Prev; 25(7); 1090-7. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27358257     DOI: 10.1158/1055-9965.EPI-15-1291

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Anal Cancer and Anal Cancer precursors in Women with a History of HPV-Related Dysplasia and Cancer.

Authors:  Elizabeth A Stier; Elizabeth Y Chiao
Journal:  Semin Colon Rectal Surg       Date:  2017-04-26

2.  Pilot Study of Markers for High-grade Anal Dysplasia in a Southern Cohort From the Women's Interagency Human Immunodeficiency Virus Study.

Authors:  Cecile D Lahiri; Minh Ly Nguyen; C Christina Mehta; Marina Mosunjac; Talaat Tadros; Elizabeth R Unger; Mangalathu S Rajeevan; Jendai Richards; Ighovwerha Ofotokun; Lisa Flowers
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

3.  Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.

Authors:  Eli D Ehrenpreis; Dylan G Smith
Journal:  Papillomavirus Res       Date:  2017-12-13

4.  The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.

Authors:  Diede L Loopik; Renée M Ebisch; Joanna IntHout; Willem J Melchers; Leon F Massuger; Ruud L Bekkers; Albert G Siebers
Journal:  Int J Cancer       Date:  2019-12-28       Impact factor: 7.396

5.  A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale.

Authors:  Gary M Clifford; Damien Georges; Meredith S Shiels; Eric A Engels; Andreia Albuquerque; Isobel Mary Poynten; Alexandra de Pokomandy; Alexandra M Easson; Elizabeth A Stier
Journal:  Int J Cancer       Date:  2020-07-29       Impact factor: 7.396

6.  Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature.

Authors:  I Kalliala; A Athanasiou; A A Veroniki; G Salanti; O Efthimiou; N Raftis; S Bowden; M Paraskevaidi; K Aro; M Arbyn; P Bennett; P Nieminen; E Paraskevaidis; M Kyrgiou
Journal:  Ann Oncol       Date:  2020-01-03       Impact factor: 32.976

7.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.

Authors:  Duncan C Gilbert; Katie Wakeham; Ruth E Langley; Claire L Vale
Journal:  Br J Cancer       Date:  2018-11-28       Impact factor: 7.640

8.  Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia.

Authors:  Mario Preti; Stefano Rosso; Leonardo Micheletti; Carola Libero; Irene Sobrato; Livia Giordano; Paola Busso; Niccolò Gallio; Stefano Cosma; Federica Bevilacqua; Chiara Benedetto
Journal:  BMC Cancer       Date:  2020-10-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.